ZH
RU
ES
genetic therapy
genetic therapy, Total:58 items.
In the international standard classification, genetic therapy involves: Radiation protection, Nuclear energy engineering, Medical sciences and health care facilities in general, Medical equipment, Laboratory medicine, Dentistry, Pharmaceutics, Acoustics and acoustic measurements, Buildings.
Association Francaise de Normalisation, genetic therapy
- NF M60-525*NF ISO 21243:2009 Radiation protection - Performance criteria for laboratories performing cytogenetic triage for assessment of mass casualties in radiological or nuclear emergencies - General principles and application to dicentric assay.
- NF EN 62555:2014 Ultrasons - Mesurage de puissance - Transducteurs et systèmes ultrasonores thérapeutiques de haute intensité (HITU)
- NF EN ISO 10993-3:2014 Évaluation biologique des dispositifs médicaux - Partie 3 : essais concernant la génotoxicité, la cancérogénicité et la toxicité sur la reproduction
- NF S99-501-3:2009 Biological evaluation of medical devices - Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity.
- NF S99-501-3*NF EN ISO 10993-3:2014 Biological evaluation of medical devices - Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity
- NF S99-503:1994 Biological evaluation of medical devices. Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity.
NZ-SNZ, genetic therapy
- AS/NZS 2394:1994 Conditioning Equipment for the Treatment of Nocturnal Enuresis (Bedwetting)
Jilin Provincial Standard of the People's Republic of China, genetic therapy
US-FCR, genetic therapy
British Standards Institution (BSI), genetic therapy
- 18/30376344 DC BS ISO 21291. Traditional Chinese medicine. Therapeutic fumigation devices
- PD ISO/TR 10993-33:2015 Biological evaluation of medical devices. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
- BS EN ISO 10993-3:2014 Biological evaluation of medical devices. Tests for genotoxicity, carcinogenicity and reproductive toxicity
Professional Standard - Medicine, genetic therapy
- YY/T 0870.1-2013 Test for genotoxicity of medical devices.Part 1:Bacterial reverse mutation test
- YY/T 0870.4-2014 Test for genotoxicity of medical devices.Part 4:Mammalian bone marrow erythocyte micronucleus test
- YY/T 0870.5-2014 Test for genotoxicity of medical devices.Part 5:Mammalian bone marrow chromosome aberration test
- YY/T 0870.2-2013 Test for genotoxicity of medical devices.Part 2:In vitro mammalian chromosome aberration test
- YY/T 1897-2023 Biological evaluation of nanomedical devices Genotoxicity test In vitro mammalian cell micronucleus test
RU-GOST R, genetic therapy
- GOST ISO 10993-3-2011 Medical devices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
- GOST R ISO 10993.3-1999 Biological evaluation of medical devices. Part 3. Tests of genotoxicity, carcinogenicity and reproductive toxicity / Note: To be replaced by GOST R ISO 10993-3 (2009).
GOSTR, genetic therapy
- GOST ISO 10993-3-2018 Medical levices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicit
- GOST ISO/TR 10993-33-2018 Medical levices. Biological evaluation of medical devices. Part 33. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
CEN - European Committee for Standardization, genetic therapy
- EN ISO 10993-3:2009 Biological evaluation of medical devices - Part 3: Tests for genotoxicity@ carcinogenicity and reproductive toxicity
国家药监局, genetic therapy
- YY/T 0870.6-2019 Medical device genotoxicity testing Part 6: In vitro mammalian cell micronucleus test
- YY/T 0870.7-2023 Genotoxicity testing for medical devices Part 7: Alkaline comet test in mammals
- YY/T 0870.2-2019 Medical device genotoxicity testing Part 2: In vitro mammalian cell chromosome aberration testing
- YY/T 0870.3-2019 Test for genotoxicity of medical devices.Part 3: In vitro mammalian cell gene mutation test using mouse lymphoma cells
VN-TCVN, genetic therapy
- TCVN 7391-3-2005 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
TH-TISI, genetic therapy
- TIS 2395.3-2008 Biological evaluation of medical devices.part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity
RO-ASRO, genetic therapy
- STAS SR EN 30993-3-1996 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenity and reproductive toxicity
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China, genetic therapy
- GB/T 16886.3-2008 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- GB/T 16886.3-1997 Biological evaluation of medical devices--Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
国家市场监督管理总局、中国国家标准化管理委员会, genetic therapy
- GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
German Institute for Standardization, genetic therapy
- DIN EN ISO 10993-3:2015-02 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014); German version EN ISO 10993-3:2014
- DIN EN 62555:2015-03 Ultrasonics - Power measurement - High intensity therapeutic ultrasound (HITU) transducers and systems (IEC 62555:2013); German version EN 62555:2014
ES-UNE, genetic therapy
- UNE-EN 62555:2014 Ultrasonics - Power measurement - High intensity therapeutic ultrasound (HITU) transducers and systems (Endorsed by AENOR in June of 2014.)
PH-BPS, genetic therapy
- PNS ISO 10993-3:2021 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
International Organization for Standardization (ISO), genetic therapy
- ISO 10993-3:1992 Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- ISO 10993-3:2003 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- ISO 10993-3:2014 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- ISO/TR 10993-33:2015 Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3
Danish Standards Foundation, genetic therapy
- DS/EN 30993-3:1994 Biological evaluation of medical devices. Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
Korean Agency for Technology and Standards (KATS), genetic therapy
- KS P ISO 10993-3:2007 Biological evaluation of medical devices－Part 3：Tests for genotoxicity, carcinogenicity and reproductive toxicity
- KS P ISO 10993-3:2018 Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- KS P ISO TR 10993-33:2019 Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3
US-AAMI, genetic therapy
- ANSI/AAMI/ISO 10993-3:2014 Biological evaluation of medical devices. Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
ZA-SANS, genetic therapy
- SANS 10993-3:2004 Biological evaluation of medical devices Part 3: Test for genotoxicity, carcinogenicity and reproductive toxicity
KR-KS, genetic therapy
- KS P ISO 10993-3-2018 Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
- KS P ISO TR 10993-33-2019 Biological evaluation of medical devices — Part 33: Guidance on tests to evaluate genotoxicity — Supplement to ISO 10993-3
European Committee for Standardization (CEN), genetic therapy
- EN ISO 10993-3:2014 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014)
- EN ISO 10993-3:2003 Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity Supersedes EN 30993-3: 1999; ISO 10993-3: 2003
International Electrotechnical Commission (IEC), genetic therapy
- IEC 62555:2013 Ultrasonics - Power measurement - High intensity therapeutic ultrasound (HITU) transducers and systems
BE-NBN, genetic therapy
- NBN-EN 30993-3-1994 Biological evaluation of medical devices - Part 3 : Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:1992)
NL-NEN, genetic therapy
- NEN-ISO 10993-3:1994 Biological evaluation of medical devices. Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:1992)
AENOR, genetic therapy
- UNE-EN ISO 10993-3:2015 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014)
Canadian Standards Association (CSA), genetic therapy
- CSA ISO-10993.3-97-CAN/CSA:1997 Evaluation Biologique Des Dispositifs Medicaux - Partie 3: Essais Concernant La Genotoxicite, La Cancerogenicite Et La Toxicite Sur La Reproduction Premiere Edition
- CSA ISO 10993.3-97-CAN/CSA:1997 Evaluation biologique des dispositifs medicaux - Partie 3: Essais concernant la genotoxicite, ia cancerogenicite et la toxicite s u r la reproduction La Premiere Edition; ISO 10993-3: 1992
Liaoning Provincial Standard of the People's Republic of China, genetic therapy
- DB2101/T 0054-2022 Technical regulations for shelter-type temporary centralized medical facilities for the prevention and control of major infectious diseases